You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Ridge Waveguide Structures in Magnesium-Doped Lithium Niobate

    SBC: ADVR, INC.            Topic: T401

    In this NASA Phase I STTR effort, the feasibility of fabricating isolated ridge waveguides in 5% magnesium-doped lithium niobate (5% MgO:LN) will be established. Ridge waveguides in MgO:LN will significantly improve the power handling and conversion efficiency, increase photonic component integration, and be well suited to space based applications. The key innovation in this effort is to combine ...

    STTR Phase I 2009 National Aeronautics and Space Administration
  2. STTR Phase II: Compact, Low-cost Remote Sensing of Methamphetamine Labs

    SBC: Bridger Photonics, Inc.            Topic: N/A

    This Small Business Technology Transfer (STTR) Phase II project addresses an urgent law enforcement need for a sensitive, portable, low-cost, laser remote sensor to detect illicit methamphetamine (meth) production labs from a distance. The research objectives are to: 1. Refine, optimize, and package laser subsystem, 2. Design, construct, and optimize receiver subsystem, 3. Integrate laser and rece ...

    STTR Phase II 2009 National Science Foundation
  3. Functional Tissue Engineering for Cartilage Repair

    SBC: Cytex Therapeutics, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Degenerative joint diseases such as osteoarthritis remain the source of significant pain and disability, affecting 20 million adults with an economic burden of over 40 billion per year to the United States. While joint replacement is a well-established procedure, its finite life span makes this treatment unacceptable for younger or more active individuals, of ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  4. Fast Spectral Imaging Device For Tumor Margin Mapping

    SBC: Zenalux Biomedical, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The American Cancer Society estimates that a total of 240,430 new breast cancers were diagnosed in 2007 (178,400 new cases of invasive breast cancer, and 62,030 new cases of in situ breast cancer). Approximately 180,000 of these patients undergo breast conserving surgery (BCS), also called lumpectomy. Multiple recent studies show that a staggering 20-70% of the ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  5. Development of ADAM10 Prodomain as a Therapeutic Agent

    SBC: BIOZYME, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Recent cancer therapies have focused on using biologics to target specific signal transduction pathways implicated in the tumor development or progression. For example, recombinant fusion proteins consisting of the extracellular domain of the immunoregluatory proteins and the constant (Fc) domain of immunoglobulin (IgG) represent a growing class of protein ther ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  6. STTR Phase I: ACC Synthesis- a way to create safer, efficacious and inexpensive Single Enantiomers

    SBC: LifeSciTech, LLC            Topic: MM

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer (STTR) Phase I project propose a new method of producing enantiomerically pure ketones through the use of ACC chiral auxiliaries. The synthesis of single enantiomer drugs is an extremely important aspect of drug development. Current methods to both produce and/ ...

    STTR Phase I 2009 National Science Foundation
  7. STTR Phase I: Increasing the Efficiency of Membrane Filtration for Drinking Water Purification through the Incorporation of Novel Anti-Biofilm Small Molecules

    SBC: AGILE SCIENCES, INC.            Topic: MM

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer Phase I Project tests the feasibility of applying Agile Sciences' technology to decreasing or eliminating biofouling on filtration membranes used for drinking water purification. The main obstacle in efficiently applying membrane filtration to provide safe dri ...

    STTR Phase I 2009 National Science Foundation
  8. STTR Phase I: Graphene-Platinum Composite for Hydrogen Fuel Cells

    SBC: Allotropica Technologies, Inc.            Topic: MM

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer Phase I project will develop a multifunctional graphene-platinum composite for hydrogen fuel cells. High performance fuel cells currently have inefficient catalyst utilization due to limited contact between Pt nanoparticles and the solid proton conductor. This ...

    STTR Phase I 2009 National Science Foundation
  9. STTR Phase I: Field-Applicable Anticorrosion Coatings Using Polyaniline Nanofibers

    SBC: RESODYN CORPORATION            Topic: MM

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer Phase I project involves the development and characterization of a new type of active anticorrosion coating with zero VOC, zero HAP, and zero heavy metal content. The coating will have no solvent or carrier, no drying time, and no curing time. This coating is b ...

    STTR Phase I 2009 National Science Foundation
  10. The identification of novel negative allosteric modulators of the nicotinic recep

    SBC: Promiliad Biopharma Incorporated            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this Phase I STTR project is to identify novel negative allosteric modulators of the nicotinic acetylcholine receptor. This project seeks to partner the drug discovery technology of the Promiliad Biopharma with the expertise of Professor Dennis McKay to identify novel and subtype selective negative allosteric modulators of the nicotinic acetylcholin ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government